Bite 1: Current scenario in HER2 and HER3 positive disease


Finish all modules to obtain your certification

Module 12 videos

2 videos

Unmet medical needs in HER2+ breast cancer

Eva Ciruelos: Hospital Universitario 12 de Octubre de Madrid

Maria Vidal: Hospital Clínic de Barcelona

Module 22 videos

2 videos

Measuring HER2 and HER3 expression in breast cancer

Aleix Prat: Hospital Clínic de Barcelona/IDIBAPS

Laia Bernet: Hospitales del Grupo Ribera Salud (Alzira, València)

Module 32 videos

2 videos

Mechanisms of resistance to anti-HER2 therapy in HER2+ disease

Joan Albanell: Hospital del Mar de Barcelona/IMIM

Sònia Pernas: Institut Català d’Oncologia (H. de Llobregat, Barcelona)

Module 42 videos

2 videos

Future therapies for HER2-expressing and HER3-expressing breast cancer

Cristina Saura: H. Universitari de la Vall d’Hebron/VHIO (Barcelona)

Santiago Escrivá de Romaní: H. Universitari de la Vall d’Hebron/VHIO (Barcelona)

Module 52 videos

2 videos

HER2low: new population and emerging drugs

Mireia Margelí: Institut Català d’Oncologia (Badalona, Barcelona)

Juan Miguel Cejalvo: Hospital Clínico Uniersitario de Valencia/INCLIVA

If you have doubts about any of the aspects of the syllabus, you can send us an email to and we will respond as soon as possible.